Saxon A, Beall G N, Rohr A S, Adelman D C
Ann Intern Med. 1987 Aug;107(2):204-15. doi: 10.7326/0003-4819-107-2-204.
Allergic reactions to the beta-lactam antibiotics (penicillins, cephalosporins, carbapenems, and monobactams) are a major factor limiting their use. Immediate hypersensitivity reactions to penicillins depend on the presence of preformed allergic (IgE) antibodies to several penicillin determinants. These materials can be used in in-vivo skin testing to exclude those patients at risk for immediate or accelerated allergic reactions. The cephalosporins have not had their relevant determinants defined as related to allergic reactions. The results of in-vivo challenges of patients with IgE to penicillin suggest the incidence of reactivity of cephalosporins in patients allergic to penicillin is less than generally appreciated. The monocyclic beta-lactam antibiotic, aztreonam (a monobactam), failed to show cross-reactivity with penicillin antibodies, because immune reactivity toward the monobactam was directed against side chain rather than nuclear determinants. On the other hand, the new bicyclic carbapenem beta-lactam drugs, represented by imipenem, showed extensive in-vivo cross-reactivity with penicillins.
对β-内酰胺类抗生素(青霉素类、头孢菌素类、碳青霉烯类和单环β-内酰胺类)的过敏反应是限制其使用的主要因素。对青霉素的速发型超敏反应取决于针对几种青霉素决定簇预先形成的过敏(IgE)抗体的存在。这些物质可用于体内皮肤试验,以排除有速发型或加速型过敏反应风险的患者。头孢菌素类与过敏反应相关的决定簇尚未明确。对青霉素IgE阳性患者进行体内激发试验的结果表明,对青霉素过敏的患者中头孢菌素类的反应发生率低于普遍认知。单环β-内酰胺类抗生素氨曲南(一种单环β-内酰胺类)未显示与青霉素抗体的交叉反应性,因为对单环β-内酰胺类的免疫反应针对的是侧链而非核心决定簇。另一方面,以亚胺培南为代表的新型双环碳青霉烯类β-内酰胺药物在体内与青霉素显示出广泛的交叉反应性。